Phio Pharmaceuticals Corp. logo
Phio Pharmaceuticals Corp. PHIO
$ 1.24 -1.98%

Annual report 2025
added 03-05-2026

report update icon

Phio Pharmaceuticals Corp. Long Term Debt Current 2011-2026 | PHIO

Annual Long Term Debt Current Phio Pharmaceuticals Corp.

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- - 35 K 135 K 125 K 116 K 107 K - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
135 K 35 K 104 K

Long Term Debt Current of other stocks in the Biotechnology industry

Issuer Long Term Debt Current Price % 24h Market Cap Country
MorphoSys AG MorphoSys AG
MOR
3.63 M - 2.43 % $ 254 M germanyGermany
Ultragenyx Pharmaceutical Ultragenyx Pharmaceutical
RARE
12 M $ 19.23 -3.85 % $ 1.9 B usaUSA
ARCA biopharma ARCA biopharma
ABIO
213 K - 1052.0 % $ 415 M usaUSA
RedHill Biopharma Ltd. RedHill Biopharma Ltd.
RDHL
353 K $ 0.8 0.89 % $ 428 M israelIsrael
Regeneron Pharmaceuticals Regeneron Pharmaceuticals
REGN
37.8 M $ 742.02 -1.94 % $ 77.6 B usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
271 K - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
181 K - -10.17 % $ 12.2 K usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
625 K - - $ 1.01 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
410 K - 1.93 % $ 17.4 M usaUSA
Akouos Akouos
AKUS
671 K - 0.23 % $ 488 M usaUSA
I-Mab I-Mab
IMAB
8.06 M - - $ 866 M chinaChina
Albireo Pharma Albireo Pharma
ALBO
3.08 M - -0.23 % $ 916 M usaUSA
Replimune Group Replimune Group
REPL
1.18 M $ 7.22 -4.24 % $ 582 M usaUSA
REGENXBIO REGENXBIO
RGNX
8.29 M $ 7.88 -4.6 % $ 406 M usaUSA
Aileron Therapeutics Aileron Therapeutics
ALRN
48 K - 10.36 % $ 9.8 M usaUSA
Aptinyx Aptinyx
APTX
337 K - -39.0 % $ 4.57 M usaUSA
Rigel Pharmaceuticals Rigel Pharmaceuticals
RIGL
614 K $ 26.2 -0.64 % $ 471 M usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
1.27 M - - $ 26.5 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
419 K - - $ 7.46 M israelIsrael
Atreca Atreca
BCEL
3.54 M - -11.76 % $ 5.79 M usaUSA
Avidity Biosciences Avidity Biosciences
RNA
3.94 M $ 13.09 -0.08 % $ 1.8 B usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
1.59 M - -24.86 % $ 820 K usaUSA
bluebird bio bluebird bio
BLUE
21.2 M - - $ 546 M usaUSA
Acasti Pharma Acasti Pharma
ACST
75 K - 4.01 % $ 150 M canadaCanada
Avid Bioservices Avid Bioservices
CDMO
1.35 M - - $ 789 M usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
5.67 M - - $ 86.2 M usaUSA
Acer Therapeutics Acer Therapeutics
ACER
104 K - 2.71 % $ 14 M usaUSA
Advaxis Advaxis
ADXS
166 K - -9.65 % $ 45.9 M usaUSA
Rhythm Pharmaceuticals Rhythm Pharmaceuticals
RYTM
650 K $ 78.52 -4.13 % $ 5.1 B usaUSA
Adaptive Biotechnologies Corporation Adaptive Biotechnologies Corporation
ADPT
8.92 M $ 12.57 -9.96 % $ 1.91 B usaUSA
Sana Biotechnology Sana Biotechnology
SANA
14.9 M $ 2.78 -8.42 % $ 704 M usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
20.7 M - 0.49 % $ 251 B cayman-islandsCayman-islands
SIGA Technologies SIGA Technologies
SIGA
595 K $ 5.35 7.76 % $ 383 M usaUSA
Alnylam Pharmaceuticals Alnylam Pharmaceuticals
ALNY
45.5 M $ 321.71 -1.96 % $ 42.1 B usaUSA
Cara Therapeutics Cara Therapeutics
CARA
1.92 M - -3.03 % $ 260 M usaUSA
ChemoCentryx ChemoCentryx
CCXI
2.81 M - - $ 3.74 B usaUSA
Silence Therapeutics plc Silence Therapeutics plc
SLN
179 K $ 4.8 -9.6 % $ 622 M britainBritain
Enochian Biosciences Enochian Biosciences
ENOB
313 K - - $ 40.5 M usaUSA